In vitro Modeling of Embryonal Tumors
Open Access
- 26 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
A subset of pediatric tumors affects very young children and are thought to arise during fetal life. A common theme is that these embryonal tumors hijack developmental programs, causing a block in differentiation and, as a consequence, unrestricted proliferation. Embryonal tumors, therefore typically maintain an embryonic gene signature not found in their differentiated progeny. Still, the processes underpinning malignant transformation remain largely unknown, which is hampering therapeutic innovation. To gain more insight into these processes, in vitro and in vivo research models are indispensable. However, embryonic development is an extremely dynamic process with continuously changing cellular identities, making it challenging to define cells-of-origin. This is crucial for the development of representative models, as targeting the wrong cell or targeting a cell within an incorrect developmental time window can result in completely different phenotypes. Recent innovations in in vitro cell models may provide more versatile platforms to study embryonal tumors in a scalable manner. In this review, we outline different in vitro models that can be explored to study embryonal tumorigenesis and for therapy development.Funding Information
- European Research Council
- KWF Kankerbestrijding
- Stichting Kinderen Kankervrij
This publication has 122 references indexed in Scilit:
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2Proceedings of the National Academy of Sciences of the United States of America, 2013
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomasActa Neuropathologica, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- Subtypes of medulloblastoma have distinct developmental originsNature, 2010
- Analysis of early human neural crest developmentDevelopmental Biology, 2010
- Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancerCancer Letters, 2009
- The cancer genomeNature, 2009
- Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiationProceedings of the National Academy of Sciences of the United States of America, 2008
- MYCN silencing induces differentiation and apoptosis in human neuroblastoma cellsBiochemical and Biophysical Research Communications, 2006
- Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesisNature, 1992